Reporter gene imaging "visualized" the integration of two growing technologies: CRISPR/Cas9-based genome editing and induced pluripotent stem cell therapy

被引：0
|
作者：
Chiti, Arturo [1 ,2 ]
机构：
[1] IRCCS, Humanitas Clin & Res Ctr, Via Manzoni 56, I-20089 Rozzano, Mi, Italy
[2] Humanitas Univ, Dept Biomed Sci, Via Rita Levi Montalcini 4, I-20090 Milan, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2021年 / 48卷 / 03期
关键词：
TRANSPLANTATION;
D O I：
10.1007/s00259-020-05117-x
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：664 / 665
页数：2
相关论文
共 50 条
  • [41] Therapeutic genome editing using CRISPR/Cas9 for arrhythmogenic cardiomyopathy induced pluripotent stem cells derived cardiac tissues
    Caspi, O. Oren
    Chrona, S.
    Gepstein, A.
    Shiti, A.
    Huber, I.
    Arbel, G.
    Gepstein, L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 3 - 3
  • [42] CRISPR/Cas9 genome editing in human pluripotent stem cell-cardiomyocytes provides a platform for modeling hypertrophic cardiomyopathy
    Mosqueira, D.
    Mannhardt, I.
    Bhagwan, J. R.
    Lis-Slimak, K.
    Katili, P.
    Scott, E.
    Hassan, M.
    Prondzynski, M.
    Harmer, S.
    Tinker, A.
    Smith, J. G. W.
    Carrier, L.
    Williams, P.
    Gaffney, D.
    Eschenhagen, T.
    Hansen, A.
    Denning, C.
    HUMAN GENE THERAPY, 2019, 30 (02) : A5 - A5
  • [43] Cellular Reprogramming, Genome Editing, and Alternative CRISPR Cas9 Technologies for Precise Gene Therapy of Duchenne Muscular Dystrophy
    Gee, Peter
    Xu, Huaigeng
    Hotta, Akitsu
    STEM CELLS INTERNATIONAL, 2017, 2017
  • [44] Generation of a MIR5004 knockout cell line from human induced pluripotent stem cells by CRISPR/Cas9 gene editing
    Gulimiheranmu, Maisumu
    Li, Shuang
    Zhou, Junmei
    STEM CELL RESEARCH, 2022, 62
  • [45] High resolution melting analysis: A rapid and sensitive method for detection of mutations induced by CRISPR/Cas9-based genome editing in oysters
    Li, Qian
    Yu, Hong
    Li, Qi
    AQUACULTURE, 2023, 572
  • [46] Vertex's CRISPR/Cas9-based gene editing therapy CASGEVY® is launched in Germany for suitable patients with beta thalassemia and sickle cell disease
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2025, 48 (03)
  • [47] Multiplex CRISPR/Cas9-Based Genome Editing of Mouse Hematopoietic Stem Cells Recapitulates Acute Erythroid Leukemia and Identifies Therapeutic Targets
    Iacobucci, Ilaria
    Varotto, Elena
    Qu, Chunxu
    Janke, Laura
    Seth, Aman
    Shelat, Anang
    Freeman, Burgess
    Kennedy, James
    Sperling, Adam S.
    Lindsley, R. Coleman
    Dickerson, Kirsten
    Payne-Turner, Debbie
    Morris, Sarah M.
    Ghosn, Nina
    Ebert, Benjamin L.
    Mullighan, Charles G.
    BLOOD, 2018, 132
  • [48] Targeted Genome Editing of Human Induced Pluripotent Stem Cells Using CRISPR/CAS9 to Generate a Knock-in Type II Collagen Reporter for the Purification of Chondrogenic Cells
    Adkar, Shaunak S.
    Willard, Vincent P.
    Brunger, Jonathan M.
    Shiao, Kenneth T.
    Gersbach, Charles A.
    Guilak, Farshid
    MOLECULAR THERAPY, 2016, 24 : S128 - S128
  • [49] Evaluation of gene expression regulation and function after CRISPR/Cas9-based genome editing strategies for the treatment of RAG1 defects
    Brandas, C.
    Porcellini, S.
    Castiello, M. C.
    Ferrari, S.
    Vavassori, V.
    Canarutto, D.
    Paulis, M.
    Strina, D.
    Merelli, I.
    Genovese, P.
    Notarangelo, L. D.
    Naldini, L.
    Villa, A.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A147 - A147
  • [50] CRISPR/Cas9-based GLA knockout to generate the female Fabry disease human induced pluripotent stem cell line MHHi001-A-15
    Juchem, Malte
    Lehmann, Nele
    Behrens, Yvonne Lisa
    Bar, Christian
    Thum, Thomas
    Hoepfner, Jeannine
    STEM CELL RESEARCH, 2024, 79
12345